netFormulary Sunderland Joint Formulary NHS
NHS Sunderland Clinical Commissioning Group
City Hospitals Sunderland NHS Foundation Trust
 
 Search
 Formulary Chapter 10: Musculoskeletal and joint diseases - Full Chapter
10.01.01  Expand sub section  Non-steroidal anti-inflammatory drugs
Ibuprofen
View adult BNF View SPC online
First Choice Tablets: 200mg, 400mg, 600mg
Suspension (sugar-free available): 100mg/5mL 
Naproxen
View adult BNF View SPC online
Second Choice Tablets: 250mg, 500mg 
   
Diclofenac sodium
View adult BNF View SPC online
Alternatives Tablets: 25mg, 50mg 
   
Celecoxib
View adult BNF View SPC online
Alternatives Capsules: 100mg, 200mg 
   
Etodolac
View adult BNF View SPC online
Alternatives Capsules: 300mg
MR tablets: 600mg 
   
Etoricoxib
View adult BNF View SPC online
Alternatives

Tablets: 30mg, 60mg, 90mg, 120mg


Indications:
Long-term for ankylosing spondylitis

 
   
Indometacin
View adult BNF View SPC online
Alternatives Capsules: 25 mg, 50 mg
SR Capsules: 75 mg
Suppositories: 100 mg
 
   
Mefenamic Acid
View adult BNF View SPC online
Alternatives Capsules: 250 mg
Tablets: 500 mg
Suspension: 50 mg/5 mL

Note: Obs & gynae use only
 
   
Diclofenac Sodium
View adult BNF View SPC online
Alternatives
Red

Injection: 75 mg/3 ml
To be used in secondary care only

 
   
Phenylbutazone
View adult BNF View SPC online
Alternatives
Red

Tablets: 100mg

Indication: Ankylosing Spondylitis. Only be used by a specialist in severe cases where other treatments have been found unsuitable
This is to be used for existing patients only. No new patients should be commenced on phenylbutazone.

 
   
Flurbiprofen
View adult BNF View SPC online
Alternatives
Red
Tablets: 50mg, 100mg
For use in Sunderland eye infirmary only 
   
10.01.01  Expand sub section  Aspirin
 ....
 Non Formulary Items
Aceclofenac

View adult BNF View SPC online
Non Formulary
 
Acelofenac  (Preservex)

View adult BNF View SPC online
Non Formulary
 
Acemetacin  (Emflex)

View adult BNF View SPC online
Non Formulary
 
Azapropazone  (Rheumox)

View adult BNF View SPC online
Non Formulary
 
Dexibuprofen  (Seractil)

View adult BNF View SPC online
Non Formulary
 
Dexketoprofen  (Keral)

View adult BNF View SPC online
Non Formulary
 
Diclofenac with Misoprostol  (Arthrotec 50 and 75)

View adult BNF View SPC online
Non Formulary
 
Dicolfenac Sodium  (Voltarol Radid)

View adult BNF View SPC online
Non Formulary
 
Fenbufen

View adult BNF View SPC online
Non Formulary
 
Ibuprofen and famotidine  (Duexis)

View adult BNF View SPC online
Non Formulary
 
Ketoprofen

View adult BNF View SPC online
Non Formulary
 
Ketoprofen  (Axorid®)

View adult BNF View SPC online
Non Formulary
 
Ketoprofen  (Orudis)

View adult BNF View SPC online
Non Formulary
 
Ketoprofen  (Oruvail)

View adult BNF View SPC online
Non Formulary
 
Ketoprofen  (Oruvail MR)

View adult BNF View SPC online
Non Formulary
 
Lumiracoxib  (Prexige)

View adult BNF View SPC online
Non Formulary
 
Meloxicam  (Mobic)

View adult BNF View SPC online
Non Formulary
 
Nabumetone

View adult BNF View SPC online
Non Formulary
 
Nabumetone  (Relifex)

View adult BNF View SPC online
Non Formulary
 
Naproxen & esomeprazole  (Vimovo)

View adult BNF View SPC online
Non Formulary
 
Naproxen with Misoprostol  (Napratec)

View adult BNF View SPC online
Non Formulary
 
Piroxicam

View adult BNF View SPC online
Non Formulary
 
Piroxicam  (Brexidol)

View adult BNF View SPC online
Non Formulary
 
Piroxicam  (Feldene)

View adult BNF View SPC online
Non Formulary
 
Sulindac

View adult BNF View SPC online
Non Formulary
 
Sulindac  (Clinoril)

View adult BNF View SPC online
Non Formulary
 
Tenoxicam  (Mobiflex)

View adult BNF View SPC online
Non Formulary
 
Tiaprofenic Acid

View adult BNF View SPC online
Non Formulary
 
Tiaprofenic Acid  (Surgam)

View adult BNF View SPC online
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs for hospital use or use by a specialist within specialist centre only. Initiation and monitoring of treatment should remain under the total responsibility of the appropriate hospital clinician or specialist. These drugs should only be prescribed under the direct supervision of that clinician or specialist and are not suitable for shared care arrangements. The drug should be supplied via the hospital or specialist centre for the duration of treatment.   

Amber

These are specialist drugs which must be initiated by secondary care specialist prescribers, but with the potential to transfer prescribing to primary care within written and agreed shared care protocols and according to the agreed process for transfer of care. For these drugs, in order to ensure patient safety, some aspects of care must remain with the specialist due to their complexity e.g. monitoring of disease or drug response. Other more routine aspects can be transferred to the GP e.g. monitoring of adverse effects and supply of the medicine. The specific responsibilities of the specialist and GP are defined in the shared care agreement for each drug. Shared care agreements are still under development for some amber drugs. Until these are available, it would be expected that any shared care request from secondary care to a GP would be accompanied by written information which defines prescribing and monitoring responsibilities. The hospital specialist should also provide the GP with enough information and support to allow the safe transfer and ongoing management of prescribing into primary care.   

Green +

Drugs which should usually be initiated in secondary care, or by a specialist clinician, but can be safely maintained in primary care with very little or no monitoring required. In some cases there may be a further restriction for use outlined - these will be defined in each case.  

Green

These are defined as new and established drugs, which may be prescribed, initiated, changed or maintained on FP10 by the GP and, if appropriate, discontinued without recourse to secondary care. N.B. DRUGS NOT IDENTIFIED IN THE FORMULARY BY A RED, AMBER OR GREEN+ SYMBOL ARE CLASSIFIED AS GREEN.   

netFormulary